O	O	O	0	10	Activation	Activation	B-NP	NN	O	0	ROOT	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T16	B-Entity	B-Entity	14	16	NF	NF	B-NP	NN	B-protein	5	NMOD	B-protein
T16	I-Entity	I-Entity	16	17	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T16	I-Entity	I-Entity	17	23	kappaB	kappaB	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	24	26	in	in	B-PP	IN	O	1	NMOD	O
O	O	O	27	40	Mycobacterium	Mycobacterium	B-NP	NN	O	8	NMOD	O
O	O	O	41	53	tuberculosis	tuberculosis	I-NP	NN	O	15	NMOD	O
O	O	O	53	54	-	-	B-VP	HYPH	O	15	P	O
O	O	O	55	62	induced	induce	B-NP	VBN	O	15	NMOD	O
O	O	O	63	74	interleukin	interleukin	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	74	75	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
O	O	O	75	76	2	2	I-NP	CD	I-protein	14	NMOD	I-protein
O	O	O	77	85	receptor	receptor	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	O	86	96	expression	expression	I-NP	NN	O	6	PMOD	O
O	O	O	97	99	in	in	B-PP	IN	O	15	NMOD	O
O	O	O	100	111	mononuclear	mononuclear	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	O	112	122	phagocytes	phagocyte	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	O	122	123	.	.	O	.	O	1	P	O

O	O	O	125	132	Soluble	Soluble	B-NP	JJ	O	7	NMOD	O
T1	B-Protein	B-Protein	133	144	interleukin	interleukin	I-NP	NN	B-protein	5	NMOD	B-protein
T1	I-Protein	I-Protein	144	145	-	-	O	HYPH	I-protein	5	P	I-protein
T1	I-Protein	I-Protein	145	146	2	2	B-NP	CD	I-protein	5	NMOD	I-protein
T1	I-Protein	I-Protein	147	155	receptor	receptor	I-NP	NN	I-protein	1	NMOD	I-protein
T1	I-Protein	I-Protein	155	156	-	-	O	HYPH	O	7	P	O
T1	I-Protein	I-Protein	156	161	alpha	alpha	B-NP	SYM	O	13	SUB	O
O	O	O	162	163	(	(	O	(	O	12	DEP	O
T2	B-Protein	B-Protein	163	165	IL	IL	B-NP	NN	B-protein	11	NMOD	B-protein
T2	I-Protein	I-Protein	165	166	-	-	B-NP	HYPH	I-protein	11	P	I-protein
T2	I-Protein	I-Protein	166	173	2Ralpha	2Ralpha	I-NP	NN	I-protein	12	DEP	I-protein
O	O	O	173	174	)	)	O	)	O	7	NMOD	O
O	O	O	175	178	has	have	B-VP	VBZ	O	30	VMOD	O
O	O	O	179	183	been	be	I-VP	VBN	O	13	VC	O
O	O	O	184	192	reported	report	I-VP	VBN	O	14	VC	O
O	O	O	193	195	to	to	I-VP	TO	O	17	VMOD	O
O	O	O	196	198	be	be	I-VP	VB	O	15	VMOD	O
O	O	O	199	208	increased	increase	I-VP	VBN	O	17	VC	O
O	O	O	209	211	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	212	215	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	216	220	sera	serum	I-NP	NNS	O	19	PMOD	O
O	O	O	221	223	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	224	232	patients	patient	B-NP	NNS	O	22	PMOD	O
O	O	O	233	237	with	with	B-PP	IN	O	23	NMOD	O
O	O	O	238	246	advanced	advance	B-NP	VBN	O	26	NMOD	O
O	O	O	247	259	tuberculosis	tuberculosis	I-NP	NN	O	24	PMOD	O
O	O	O	259	260	,	,	O	,	O	30	P	O
O	O	O	261	264	and	and	O	CC	O	30	VMOD	O
O	O	O	265	271	levels	level	B-NP	NNS	O	30	SUB	O
O	O	O	272	279	decline	decline	B-VP	VBP	O	0	ROOT	O
O	O	O	280	285	after	after	B-PP	IN	O	30	VMOD	O
O	O	O	286	293	therapy	therapy	B-NP	NN	O	31	PMOD	O
O	O	O	294	296	in	in	B-PP	IN	O	30	VMOD	O
O	O	O	297	307	accordance	accordance	B-NP	NN	O	33	PMOD	O
O	O	O	308	312	with	with	B-PP	IN	O	33	PMOD	O
O	O	O	313	324	improvement	improvement	B-NP	NN	O	33	PMOD	O
O	O	O	325	327	of	of	B-PP	IN	O	36	NMOD	O
O	O	O	328	338	radiologic	radiologic	B-NP	JJ	O	39	NMOD	O
O	O	O	339	347	findings	finding	I-NP	NNS	O	37	PMOD	O
O	O	O	347	348	.	.	O	.	O	30	P	O

O	O	O	349	351	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	352	364	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	O	365	375	expression	expression	B-NP	NN	O	2	OBJ	O
O	O	O	376	378	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	379	382	the	the	B-NP	DT	O	8	NMOD	O
T3	B-Protein	B-Protein	383	385	IL	IL	I-NP	NN	B-protein	8	NMOD	B-protein
T3	I-Protein	I-Protein	385	386	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T3	I-Protein	I-Protein	386	393	2Ralpha	2Ralpha	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	394	396	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	397	412	bronchoalveolar	bronchoalveolar	B-NP	JJ	B-cell_type	15	NMOD	B-cell_type
O	O	O	413	419	lavage	lavage	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	O	420	421	(	(	O	(	I-cell_type	15	NMOD	I-cell_type
O	O	O	421	424	BAL	BAL	B-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	O	424	425	)	)	O	)	I-cell_type	15	NMOD	I-cell_type
O	O	O	426	431	cells	cell	B-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	O	432	434	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	435	441	active	active	B-NP	JJ	O	19	NMOD	O
O	O	O	442	451	pulmonary	pulmonary	I-NP	JJ	O	19	NMOD	O
O	O	O	452	464	tuberculosis	tuberculosis	I-NP	NN	O	16	PMOD	O
O	O	O	464	465	,	,	O	,	O	2	P	O
O	O	O	466	469	and	and	O	CC	O	2	VMOD	O
O	O	O	470	479	evaluated	evaluate	B-VP	VBD	O	2	VMOD	O
O	O	O	480	483	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	484	493	mechanism	mechanism	I-NP	NN	O	26	NMOD	O
O	O	O	494	507	Mycobacterium	Mycobacterium	I-NP	NN	O	26	NMOD	O
O	O	O	508	520	tuberculosis	tuberculosis	I-NP	NN	O	22	OBJ	O
O	O	O	521	528	induces	induce	B-VP	VBZ	O	22	VMOD	O
O	O	O	529	531	in	in	B-PP	IN	O	27	VMOD	O
O	O	O	532	535	the	the	B-NP	DT	O	32	NMOD	O
T4	B-Protein	B-Protein	536	538	IL	IL	I-NP	NN	B-protein	32	NMOD	B-protein
T4	I-Protein	I-Protein	538	539	-	-	B-NP	HYPH	I-protein	32	NMOD	I-protein
T4	I-Protein	I-Protein	539	546	2Ralpha	2Ralpha	I-NP	NN	I-protein	28	PMOD	I-protein
O	O	O	547	552	using	use	B-VP	VBG	O	27	VMOD	O
O	O	O	553	556	the	the	B-NP	DT	O	41	NMOD	O
O	O	O	557	560	THP	THP	I-NP	NN	B-cell_line	41	NMOD	B-cell_line
O	O	O	560	561	-	-	B-NP	HYPH	I-cell_line	41	NMOD	I-cell_line
O	O	O	561	562	1	1	I-NP	CD	I-cell_line	41	NMOD	I-cell_line
O	O	O	563	574	mononuclear	mononuclear	I-NP	JJ	I-cell_line	41	NMOD	I-cell_line
O	O	O	575	584	phagocyte	phagocyte	I-NP	NN	I-cell_line	41	NMOD	I-cell_line
O	O	O	585	589	cell	cell	I-NP	NN	I-cell_line	41	NMOD	I-cell_line
O	O	O	590	594	line	line	I-NP	NN	I-cell_line	33	OBJ	I-cell_line
O	O	O	594	595	.	.	O	.	O	2	P	O

O	O	O	596	598	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	599	604	found	find	B-VP	VBD	O	0	ROOT	O
T5	B-Protein	B-Protein	605	607	IL	IL	B-NP	NN	B-protein	6	NMOD	B-protein
T5	I-Protein	I-Protein	607	608	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T5	I-Protein	I-Protein	608	615	2Ralpha	2Ralpha	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	616	626	expression	expression	I-NP	NN	O	8	SUB	O
O	O	O	627	629	to	to	B-VP	TO	O	8	VMOD	O
O	O	O	630	632	be	be	I-VP	VB	O	2	VMOD	O
O	O	O	633	642	increased	increase	I-VP	VBN	O	8	VC	O
O	O	O	643	645	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	646	649	BAL	BAL	B-NP	NN	B-cell_type	12	NMOD	B-cell_type
O	O	O	650	655	cells	cell	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	O	656	660	from	from	B-PP	IN	O	12	NMOD	O
O	O	O	661	669	involved	involve	B-NP	VBN	O	15	NMOD	O
O	O	O	670	675	sites	site	I-NP	NNS	O	13	PMOD	O
O	O	O	676	678	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	679	685	active	active	B-NP	JJ	O	19	NMOD	O
O	O	O	686	695	pulmonary	pulmonary	I-NP	JJ	O	19	NMOD	O
O	O	O	696	708	tuberculosis	tuberculosis	I-NP	NN	O	16	PMOD	O
O	O	O	708	709	.	.	O	.	O	2	P	O

O	O	O	710	720	Expression	Expression	B-NP	NN	O	18	SUB	O
O	O	O	721	723	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	724	727	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	728	733	alpha	alpha	I-NP	SYM	B-protein	6	NMOD	B-protein
O	O	O	733	734	-	-	I-NP	HYPH	I-protein	6	NMOD	I-protein
O	O	O	734	739	chain	chain	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	740	742	of	of	B-PP	IN	O	6	NMOD	O
T6	B-Protein	B-Protein	743	745	IL	IL	B-NP	NN	B-protein	10	NMOD	B-protein
T6	I-Protein	I-Protein	745	746	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T6	I-Protein	I-Protein	746	753	2Ralpha	2Ralpha	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	O	754	756	on	on	B-PP	IN	O	1	NMOD	O
O	O	O	757	767	peripheral	peripheral	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	768	773	blood	blood	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	774	783	monocytes	monocyte	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	O	784	785	(	(	O	(	O	17	DEP	O
O	O	O	785	788	PBM	PBM	B-NP	NNS	B-cell_type	17	DEP	B-cell_type
O	O	O	788	789	)	)	O	)	O	14	NMOD	O
O	O	O	790	793	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	794	801	induced	induce	I-VP	VBN	O	18	VC	O
O	O	O	802	804	by	by	B-PP	IN	O	19	VMOD	O
O	O	O	805	806	M	M	B-NP	NN	O	20	PMOD	O
O	O	O	806	807	.	.	O	.	O	18	VMOD	O
O	O	O	808	820	tuberculosis	tuberculosis	B-NP	NN	O	22	OBJ	O
O	O	O	821	823	by	by	B-PP	IN	O	23	NMOD	O
O	O	O	824	828	flow	flow	B-NP	NN	O	27	NMOD	O
O	O	O	829	838	cytometry	cytometry	I-NP	NN	O	27	NMOD	O
O	O	O	839	849	evaluation	evaluation	I-NP	NN	O	24	PMOD	O
O	O	O	849	850	.	.	O	.	O	18	P	O

O	O	O	851	859	Northern	Northern	B-NP	NN	O	2	NMOD	O
O	O	O	860	868	analysis	analysis	I-NP	NN	O	3	SUB	O
O	O	O	869	881	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	O	882	891	increased	increase	B-NP	VBN	O	9	NMOD	O
T7	B-Protein	B-Protein	892	894	IL	IL	I-NP	NN	B-protein	9	NMOD	B-protein
T7	I-Protein	I-Protein	894	895	-	-	I-NP	HYPH	I-protein	9	P	I-protein
T7	I-Protein	I-Protein	895	902	2Ralpha	2Ralpha	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	903	907	gene	gene	I-NP	NN	O	9	NMOD	O
O	O	O	908	918	expression	expression	I-NP	NN	O	3	OBJ	O
O	O	O	919	924	after	after	B-PP	IN	O	9	NMOD	O
O	O	O	925	936	stimulation	stimulation	B-NP	NN	O	10	PMOD	O
O	O	O	937	941	with	with	B-PP	IN	O	11	NMOD	O
O	O	O	942	943	M	M	B-NP	NN	O	12	PMOD	O
O	O	O	943	944	.	.	O	.	O	3	VMOD	O
O	O	O	945	957	tuberculosis	tuberculosis	B-NP	NN	O	14	OBJ	O
O	O	O	958	963	which	which	B-NP	WDT	O	15	NMOD	O
O	O	O	964	967	was	be	B-VP	VBD	O	16	SBAR	O
O	O	O	968	975	further	further	I-VP	RBR	O	19	VMOD	O
O	O	O	976	983	induced	induce	I-VP	VBN	O	17	VC	O
O	O	O	984	986	by	by	B-PP	IN	O	19	VMOD	O
T8	B-Protein	B-Protein	987	997	interferon	interferon	B-NP	NN	B-protein	23	NMOD	B-protein
T8	I-Protein	I-Protein	997	998	-	-	O	HYPH	I-protein	23	P	I-protein
T8	I-Protein	I-Protein	998	1003	gamma	gamma	B-NP	SYM	I-protein	20	PMOD	I-protein
O	O	O	1004	1005	(	(	O	(	O	28	DEP	O
T9	B-Protein	B-Protein	1005	1008	IFN	IFN	B-NP	NN	B-protein	27	NMOD	B-protein
T9	I-Protein	I-Protein	1008	1009	-	-	O	HYPH	I-protein	27	P	I-protein
T9	I-Protein	I-Protein	1009	1014	gamma	gamma	B-NP	NN	I-protein	28	DEP	I-protein
O	O	O	1014	1015	)	)	O	)	O	23	NMOD	O
O	O	O	1015	1016	.	.	O	.	O	3	P	O

O	O	O	1017	1020	The	The	B-NP	DT	O	5	NMOD	O
T10	B-Protein	B-Protein	1021	1023	IL	IL	I-NP	NN	B-DNA	5	NMOD	B-DNA
T10	I-Protein	I-Protein	1023	1024	-	-	I-NP	HYPH	I-DNA	5	NMOD	I-DNA
T10	I-Protein	I-Protein	1024	1031	2Ralpha	2Ralpha	I-NP	NN	I-DNA	5	NMOD	I-DNA
T17	B-Entity	B-Entity	1032	1040	promoter	promoter	I-NP	NN	I-DNA	18	SUB	I-DNA
O	O	O	1041	1051	containing	contain	B-VP	VBG	O	5	NMOD	O
O	O	O	1052	1055	the	the	B-NP	DT	O	17	NMOD	O
T18,T19	B-Entity,B-Entity	B-Entity,B-Entity	1056	1063	nuclear	nuclear	I-NP	JJ	B-DNA	17	NMOD	B-DNA
T18,T19	I-Entity,I-Entity	I-Entity,I-Entity	1064	1070	factor	factor	I-NP	NN	I-DNA	17	NMOD	I-DNA
T18,T19	I-Entity,I-Entity	I-Entity,I-Entity	1071	1076	kappa	kappa	I-NP	NN	I-DNA	17	NMOD	I-DNA
T18,T19	I-Entity,I-Entity	I-Entity,I-Entity	1077	1078	B	B	I-NP	NN	I-DNA	17	NMOD	I-DNA
T18	I-Entity	I-Entity	1079	1080	(	(	O	(	I-DNA	16	DEP	I-DNA
T18,T20	I-Entity,B-Entity	I-Entity,B-Entity	1080	1082	NF	NF	B-NP	NN	I-DNA	15	NMOD	I-DNA
T18,T20	I-Entity,I-Entity	I-Entity,I-Entity	1082	1083	-	-	B-NP	HYPH	I-DNA	15	P	I-DNA
T18,T20	I-Entity,I-Entity	I-Entity,I-Entity	1083	1089	kappaB	kappaB	I-NP	NN	I-DNA	16	DEP	I-DNA
T18	I-Entity	I-Entity	1089	1090	)	)	O	)	I-DNA	17	NMOD	I-DNA
T18	I-Entity	I-Entity	1091	1095	site	site	B-NP	NN	I-DNA	6	OBJ	I-DNA
O	O	O	1096	1099	was	be	B-VP	VBD	O	31	VMOD	O
O	O	O	1100	1117	transcriptionally	transcriptionally	I-VP	RB	O	18	VMOD	O
O	O	O	1118	1125	induced	induce	I-VP	VBN	O	18	VC	O
O	O	O	1126	1128	by	by	B-PP	IN	O	20	VMOD	O
O	O	O	1129	1130	M	M	B-NP	NN	O	21	PMOD	O
O	O	O	1130	1131	.	.	O	.	O	18	P	O
O	O	O	1132	1144	tuberculosis	tuberculosis	B-NP	NN	O	30	NMOD	O
O	O	O	1145	1148	and	and	O	CC	O	30	NMOD	O
O	O	O	1149	1153	this	this	B-NP	DT	O	30	NMOD	O
T21,T22	B-Entity,B-Entity	B-Entity,B-Entity	1154	1156	NF	NF	I-NP	NN	O	30	NMOD	O
T21,T22	I-Entity,I-Entity	I-Entity,I-Entity	1156	1157	-	-	B-NP	HYPH	O	30	NMOD	O
T21,T22	I-Entity,I-Entity	I-Entity,I-Entity	1157	1163	kappaB	kappaB	I-NP	NN	B-DNA	30	NMOD	B-DNA
T21	I-Entity	I-Entity	1164	1168	site	site	I-NP	NN	I-DNA	31	SUB	I-DNA
O	O	O	1169	1174	could	could	B-VP	MD	O	0	ROOT	O
O	O	O	1175	1181	confer	confer	I-VP	VB	O	31	VC	O
O	O	O	1182	1194	inducibility	inducibility	B-NP	NN	O	32	OBJ	O
O	O	O	1195	1197	to	to	B-PP	TO	O	32	VMOD	O
O	O	O	1198	1199	a	a	B-NP	DT	O	43	NMOD	O
T23	B-Entity	B-Entity	1200	1212	heterologous	heterologous	I-NP	JJ	B-DNA	43	NMOD	B-DNA
T23	I-Entity	I-Entity	1213	1219	herpes	herpes	I-NP	NN	I-DNA	43	NMOD	I-DNA
T23	I-Entity	I-Entity	1220	1229	thymidine	thymidine	I-NP	NN	I-DNA	43	NMOD	I-DNA
T23	I-Entity	I-Entity	1230	1236	kinase	kinase	I-NP	NN	I-DNA	43	NMOD	I-DNA
T23	I-Entity	I-Entity	1237	1238	(	(	O	(	I-DNA	43	NMOD	I-DNA
T23	I-Entity	I-Entity	1238	1240	TK	TK	B-NP	NN	I-DNA	43	NMOD	I-DNA
T23	I-Entity	I-Entity	1240	1241	)	)	O	)	I-DNA	43	NMOD	I-DNA
T23	I-Entity	I-Entity	1242	1250	promoter	promoter	B-NP	NN	I-DNA	34	PMOD	I-DNA
O	O	O	1251	1253	by	by	B-PP	IN	O	43	NMOD	O
O	O	O	1254	1255	M	M	B-NP	NN	O	44	PMOD	O
O	O	O	1255	1256	.	.	O	.	O	47	NMOD	O
O	O	O	1257	1269	tuberculosis	tuberculosis	B-NP	NN	O	31	VMOD	O
O	O	O	1269	1270	.	.	O	.	O	31	P	O

O	O	O	1271	1286	Electrophoretic	Electrophoretic	B-NP	JJ	O	4	NMOD	O
O	O	O	1287	1295	mobility	mobility	I-NP	NN	O	4	NMOD	O
O	O	O	1296	1301	shift	shift	I-NP	NN	O	4	NMOD	O
O	O	O	1302	1308	assays	assay	I-NP	NNS	O	8	SUB	O
O	O	O	1309	1310	(	(	O	(	O	7	DEP	O
O	O	O	1310	1315	EMSAs	EMSA	B-NP	NNS	O	7	DEP	O
O	O	O	1315	1316	)	)	O	)	O	4	NMOD	O
O	O	O	1317	1325	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	O	1326	1334	specific	specific	B-NP	JJ	O	10	NMOD	O
O	O	O	1335	1342	binding	binding	I-NP	NN	O	8	OBJ	O
O	O	O	1343	1345	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	1346	1353	nuclear	nuclear	B-NP	JJ	B-protein	13	NMOD	B-protein
O	O	O	1354	1361	protein	protein	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	O	1362	1364	to	to	B-PP	TO	O	10	NMOD	O
O	O	O	1365	1368	the	the	B-NP	DT	O	19	NMOD	O
T24,T25	B-Entity,B-Entity	B-Entity,B-Entity	1369	1371	NF	NF	I-NP	NN	B-DNA	19	NMOD	B-DNA
T24,T25	I-Entity,I-Entity	I-Entity,I-Entity	1371	1372	-	-	B-NP	HYPH	I-DNA	19	NMOD	I-DNA
T24,T25	I-Entity,I-Entity	I-Entity,I-Entity	1372	1378	kappaB	kappaB	I-NP	NN	I-DNA	19	NMOD	I-DNA
T24	I-Entity	I-Entity	1379	1383	site	site	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	O	1384	1388	upon	upon	B-PP	IN	O	10	NMOD	O
O	O	O	1389	1398	induction	induction	B-NP	NN	O	20	PMOD	O
O	O	O	1399	1403	with	with	B-PP	IN	O	21	NMOD	O
O	O	O	1404	1405	M	M	B-NP	NN	O	22	PMOD	O
O	O	O	1405	1406	.	.	O	.	O	8	P	O
O	O	O	1407	1419	tuberculosis	tuberculosis	B-NP	NN	O	8	VMOD	O
O	O	O	1419	1420	.	.	O	.	O	8	P	O

O	O	O	1421	1426	Using	Use	B-VP	VBG	O	24	VMOD	O
O	O	O	1427	1437	antibodies	antibody	B-NP	NNS	B-protein	1	OBJ	B-protein
O	O	O	1438	1445	against	against	B-PP	IN	O	1	VMOD	O
O	O	O	1446	1449	the	the	B-NP	DT	O	8	NMOD	O
T11	B-Protein	B-Protein	1450	1453	p50	p50	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	1454	1457	and	and	I-NP	CC	O	8	NMOD	O
T12	B-Protein	B-Protein	1458	1461	p65	p65	I-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	1462	1470	subunits	subunit	I-NP	NNS	I-protein	3	PMOD	I-protein
O	O	O	1471	1473	of	of	B-PP	IN	O	8	NMOD	O
T26	B-Entity	B-Entity	1474	1476	NF	NF	B-NP	NN	B-protein	12	NMOD	B-protein
T26	I-Entity	I-Entity	1476	1477	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T26	I-Entity	I-Entity	1477	1483	kappaB	kappaB	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	O	1484	1486	in	in	B-PP	IN	O	1	VMOD	O
O	O	O	1487	1492	EMSAs	EMSA	B-NP	NNS	O	13	PMOD	O
O	O	O	1492	1493	,	,	O	,	O	24	P	O
O	O	O	1494	1497	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	1498	1509	involvement	involvement	I-NP	NN	O	24	SUB	O
O	O	O	1510	1512	of	of	B-PP	IN	O	17	NMOD	O
O	O	O	1513	1517	both	both	O	CC	O	23	NMOD	O
T13	B-Protein	B-Protein	1518	1521	p50	p50	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	1522	1525	and	and	O	CC	O	23	NMOD	O
T14	B-Protein	B-Protein	1526	1529	p65	p65	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	1530	1538	proteins	protein	I-NP	NNS	I-protein	18	PMOD	I-protein
O	O	O	1539	1542	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1543	1550	further	further	I-VP	RBR	O	26	VMOD	O
O	O	O	1551	1563	demonstrated	demonstrate	I-VP	VBN	O	24	VC	O
O	O	O	1563	1564	.	.	O	.	O	24	P	O

O	O	O	1565	1575	Functional	Functional	B-NP	JJ	O	2	NMOD	O
O	O	O	1576	1586	expression	expression	I-NP	NN	O	0	ROOT	O
O	O	O	1587	1589	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	1590	1593	the	the	B-NP	DT	O	7	NMOD	O
T15	B-Protein	B-Protein	1594	1596	IL	IL	I-NP	NN	B-protein	7	NMOD	B-protein
T15	I-Protein	I-Protein	1596	1597	-	-	O	HYPH	I-protein	7	NMOD	I-protein
T15	I-Protein	I-Protein	1597	1604	2Ralpha	2Ralpha	B-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	1605	1607	on	on	B-PP	IN	O	2	NMOD	O
O	O	O	1608	1619	mononuclear	mononuclear	B-NP	JJ	B-cell_type	10	NMOD	B-cell_type
O	O	O	1620	1630	phagocytes	phagocyte	I-NP	NNS	I-cell_type	8	PMOD	I-cell_type
O	O	O	1631	1633	in	in	B-PP	IN	O	10	NMOD	O
O	O	O	1634	1635	M	M	B-NP	NN	O	11	PMOD	O
O	O	O	1635	1636	.	.	O	.	O	2	NMOD	O
O	O	O	1637	1649	tuberculosis	tuberculosis	B-NP	NN	O	15	NMOD	O
O	O	O	1650	1659	infection	infection	I-NP	NN	O	16	SUB	O
O	O	O	1660	1663	may	may	B-VP	MD	O	13	SBAR	O
O	O	O	1664	1668	play	play	I-VP	VB	O	16	VC	O
O	O	O	1669	1671	an	an	B-NP	DT	O	21	NMOD	O
O	O	O	1672	1681	important	important	I-NP	JJ	O	21	NMOD	O
O	O	O	1682	1698	immunomodulatory	immunomodulatory	I-NP	JJ	O	21	NMOD	O
O	O	O	1699	1703	role	role	I-NP	NN	O	17	OBJ	O
O	O	O	1704	1706	in	in	B-PP	IN	O	17	VMOD	O
O	O	O	1707	1710	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	1711	1715	host	host	I-NP	NN	O	25	NMOD	O
O	O	O	1716	1724	response	response	I-NP	NN	O	22	PMOD	O
O	O	O	1724	1725	.	.	O	.	O	2	P	O
